|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
Statistics. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Siegel RL and Jemal A: Lung
cancer statistics. Adv Exp Med Biol. 893:1–19. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shao Y, Liang B, Long F and Jiang SJ:
Diagnostic microRNA biomarker discovery for non-small-cell lung
cancer adenocarcinoma by integrative bioinformatics analysis.
Biomed Res Int. 2017:25630852017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Butler LM, Montague JA, Koh WP, Wang R, Yu
MC and Yuan JM: Fried meat intake is a risk factor for lung
adenocarcinoma in a prospective cohort of Chinese men and women in
Singapore. Carcinogenesis. 34:1794–1799. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Paris C, Clement-Duchene C, Vignaud JM,
Gislard A, Stoufflet A, Bertrand O, Thiberville L, Grosdidier G,
Martinet Y, Benichou J, et al: Relationships between lung
adenocarcinoma and gender, age, smoking and occupational risk
factors: A case-case study. Lung Cancer. 68:146–153. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Christodoulatos GS and Dalamaga M:
Micro-RNAs as clinical biomarkers and therapeutic targets in breast
cancer: Quo vadis? World J Clin Oncol. 5:71–81. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Subtil FS, Wilhelm J, Bill V, Westholt N,
Rudolph S, Fischer J, Scheel S, Seay U, Fournier C, Taucher-Scholz
G, et al: Carbon ion radiotherapy of human lung cancer attenuates
HIF-1 signaling and acts with considerably enhanced therapeutic
efficiency. FASEB J. 28:1412–1421. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Flynt AS and Lai EC: Biological principles
of microRNA-mediated regulation: Shared themes amid diversity. Nat
Rev Genet. 9:831–842. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lauressergues D, Couzigou JM, Clemente HS,
Martinez Y, Dunand C, Bécard G and Combier JP: Primary transcripts
of microRNAs encode regulatory peptides. Nature. 520:90–93. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Voinnet O: Origin, biogenesis, and
activity of plant microRNAs. Cell. 136:669–687. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Di Giacomo G, Koss M, Capellini TD,
Brendolan A, Pöpperl H and Selleri L: Spatio-temporal expression of
Pbx3 during mouse organogenesis. Gene Expr Patterns. 6:747–757.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lichtenauer UD, Duchniewicz M, Kolanczyk
M, Hoeflich A, Hahner S, Else T, Bicknell AB, Zemojtel T, Stallings
NR, Schulte DM, et al: Pre-B-cell transcription factor 1 and
steroidogenic factor 1 synergistically regulate adrenocortical
growth and steroidogenesis. Endocrinology. 148:693–704. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Salvi A, Sabelli C, Moncini S, Venturin M,
Arici B, Riva P, Portolani N, Giulini SM, De Petro G and Barlati S:
MicroRNA-23b mediates urokinase and c-met downmodulation and a
decreased migration of human hepatocellular carcinoma cells. FEBS
J. 276:2966–2982. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Majid S, Dar AA, Saini S, Arora S,
Shahryari V, Zaman MS, Chang I, Yamamura S, Tanaka Y, Deng G, et
al: miR-23b represses proto-oncogene Src kinase and functions as
methylation-silenced tumor suppressor with diagnostic and
prognostic significance in prostate cancer. Cancer Res.
72:6435–6446. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Majid S, Dar AA, Saini S, Deng G, Chang I,
Greene K, Tanaka Y, Dahiya R and Yamamura S: MicroRNA-23b functions
as a tumor suppressor by regulating Zeb1 in bladder cancer. PLoS
One. 8:e676862013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li W, Liu Z, Chen L, Zhou L and Yao Y:
MicroRNA-23b is an independent prognostic marker and suppresses
ovarian cancer progression by targeting runt-related transcription
factor-2. FEBS Lett. 588:1608–1615. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cao J, Liu J, Long J, Fu J, Huang L, Li J,
Liu C, Zhang X and Yan Y: microRNA-23b suppresses
epithelial-mesenchymal transition (EMT) and metastasis in
hepatocellular carcinoma via targeting Pyk2. Biomed Pharmacother.
89:642–650. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang Y, Han JJ, Liang XY, Zhao L, Zhang
F, Rasouli J, Wang ZZ, Zhang GX and Li X: miR-23b suppresses
leukocyte migration and pathogenesis of experimental autoimmune
encephalomyelitis by targeting CCL7. Mol Ther. 26:582–592. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Horne MC, Goolsby GL, Donaldson KL, Tran
D, Neubauer M and Wahl AF: Cyclin G1 and cyclin G2 comprise a new
family of cyclins with contrasting tissue-specific and cell
cycle-regulated expression. J Biol Chem. 1271:6050–6061. 1996.
View Article : Google Scholar
|
|
22
|
Ye XX, Liu CB, Chen JY, Tao BH and Zhi-Yi
C: The expression of cyclin G in nasopharyngeal carcinoma and its
significance. Clin Exp Med. 12:21–24. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liang J, Bian ML, Chen QY, Liu X, Ou H, Li
M and Liu J: Relationship between cyclin G1 and human papilloma
virus infection in cervical intraepithelial neoplasia and cervical
carcinoma. Chin Med Sci J. 21:81–85. 2006.PubMed/NCBI
|
|
24
|
Wen W, Han T, Chen C, Huang L, Sun W, Wang
X, Chen SZ, Xiang DM, Tang L, Cao D, et al: Cyclin G1 expands liver
tumor-initiating cells by Sox2 induction via Akt/mTOR signaling.
Mol Cancer Ther. 12:1796–1804. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Reimer CL, Borras AM, Kurdistani SK,
Garreau JR, Chung M, Aaronson SA and Lee SW: Altered regulation of
cyclin G in human breast cancer and its specific localization at
replication foci in response to DNA damage in p53+/+
cells. J Biol Chem. 274:11022–11029. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhao X, Liu M and Li D: Oleanolic acid
suppresses the proliferation of lung carcinoma cells by
miR-122/Cyclin G1/MEF2D axis. Mol Cell Biochem. 400:1–7. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu X, Ma L, Rao Q, Mao Y, Xin Y, Xu H, Li
C and Wang X: MiR-1271 inhibits ovarian cancer growth by targeting
cyclin G1. Med Sci Monit. 21:3152–3158. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yan J, Jiang JY, Meng XN, Xiu YL and Zong
ZH: miR-23b targets cyclin G1 and suppresses ovarian cancer
tumorigenesis and progression. J Exp Clin Cancer Res. 35:312016.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Iorio MV and Croce CM: MicroRNAs in
cancer: Small molecules with a huge impact. J Clin Oncol.
27:5848–5856. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jiang C, Chen X, Alattar M, Wei J and Liu
H: MicroRNAs in tumorigenesis, metastasis, diagnosis and prognosis
of gastric cancer. Cancer Gene Ther. 22:291–301. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhu Y, Li T, Chen G, Yan G, Zhang X, Wan
Y, Li Q, Zhu B and Zhuo W: Identification of a serum microRNA
expression signature for detection of lung cancer, involving
miR-23b, miR-221, miR-148b and miR-423-3p. Lung Cancer. 114:6–11.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Pan Y, Ye C, Tian Q, Yan S, Zeng X, Xiao
C, Wang L and Wang H: miR-145 suppresses the proliferation,
invasion and migration of NSCLC cells by regulating the BAX/BCL-2
ratio and the caspase-3 cascade. Oncol Lett. 15:4337–4343.
2018.PubMed/NCBI
|
|
34
|
Seo HR, Lee DH, Lee HJ, Baek M, Bae S, Soh
JW, Lee SJ, Kim J and Lee YS: Cyclin G1 overcomes radiation-induced
G2 arrest and increases cell death through transcriptional
activation of cyclin B1. Cell Death Differ. 13:1475–1484. 2006.
View Article : Google Scholar : PubMed/NCBI
|
